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Abstract
 
Reactive oxygen intermediates (ROI) contribute to neuronal
injury in cerebral ischemia and trauma. In this study we ex-
plored the role of ROI in bacterial meningitis. Meningitis
caused by group B streptococci in infant rats led to two dis-
tinct forms of neuronal injury, areas of necrosis in the cortex
and neuronal loss in the dentate gyrus of the hippocampus,
the latter showing evidence for apoptosis. Staining of brain
sections with diaminobenzidine after perfusion with manga-
nese buffer and measurement of lipid peroxidation products
in brain homogenates both provided evidence that meningi-
tis led to the generation of ROI. Treatment with the radical
scavenger
 
 
 
a
 
-phenyl-
 
tert
 
-butyl nitrone (PBN) (100 mg/kg
q8h i.p.) beginning at the time of infection completely abol-
ished ROI detection and the increase in lipidperoxidation.
Cerebral cortical perfusion was reduced in animals with
meningitis to 37.5
 
6
 
21.0% of uninfected controls (
 
P
 
 
 
,
 
 0.05),
and PBN restored cortical perfusion to 72.0
 
6
 
8.1% of con-
trols (
 
P 
 
,
 
 0.05 vs meningitis). PBN also completely pre-
vented neuronal injury in the cortex and hippocampus,
when started at the time of infection (
 
P 
 
,
 
 0.02), and signifi-
cantly reduced both forms of injury, when started 18 h after
infection together with antibiotics (
 
P 
 
,
 
 0.004 for cortex and
 
P 
 
,
 
 0.001 for hippocampus). These data indicate that the
generation of ROI is a major contributor to cerebral is-
chemia and necrotic and apoptotic neuronal injury in this
model of neonatal meningitis. (
 
J. Clin. Invest. 
 
1996. 98:
2632–2639.) Key words: oxidative brain injury 
 
• 
 
lipidperoxi-
dation 
 
• 
 
reactive oxygen intermediates 
 
• 
 
programmed cell
death 
 
• 
 
cerebral cortical perfusion
 
Introduction
 
Reactive oxygen intermediates (ROI)
 
1
 
 like superoxide anions
and hydroxyl radicals can damage cells by oxidizing membrane
phospholipids, proteins, nucleic acids, and nucleotides. ROI
have been implicated in the pathogenesis of injury to neurons
in a variety of central nervous system (CNS) insults, including
cerebral inflammation (1), CNS trauma (2), ischemia-reperfu-
sion injury (3), and glutamate mediated excitotoxicity (4). Sev-
eral factors make the CNS particularly susceptible to oxidative
damage. The brain receives 
 
z
 
 20% of the cardiac blood output
and has thus a high oxygen tension; brain cell membranes are
rich in polyunsaturated fatty acids that can be oxidized by
ROI; brain tissue has relatively low levels of endogenous anti-
oxidant defense systems (e.g., superoxide dismutase, catalase,
glutathione peroxidase) (5); and high concentration of iron in
brain tissue promotes ROI generation (6, 7).
Bacterial meningitis continues to result in significant brain
injury in many affected patients, despite the use of highly ac-
tive antibiotics (8). In neonates, the patient population with
the most severe form of bacterial meningitis, mortality rates
can be as high as 30%, and up to 50% of surviving children are
left with significant neurological sequelae (9). The mechanisms
of CNS damage during meningitis have not been conclusively
identified, but several lines of evidence indicate that ROI may
contribute to brain injury. Inflammation has been strongly
linked to the development of brain injury in experimental
models of meningitis, and the major inflammatory cells in bac-
terial meningitis are neutrophilic granulocytes, which are po-
tent generators of ROI (1). Inflammatory involvement of the
cerebral vasculature has been suggested to be a major contrib-
utor to ischemic brain injury during meningitis (10), and cere-
bral vascular reactivity has been shown to be modulated by
ROI in experimental meningitis (11, 12). Finally, neuronal in-
jury in meningitis is in part caused by increased concentrations
of excitatory amino acid (13, 14), and the neurotoxic effect of
excitatory amino acids has been clearly linked to the genera-
tion of ROI (15–17). Despite these indirect lines of evidence
linking the generation of ROI to the pathophysiology of men-
ingitis, more direct evidence for a causative role of ROI in the
development of neuronal injury has yet to be established.
Spin trapping agents react with ROI to form relatively sta-
ble adducts which in turn can be detected by spin resonance
spectroscopy (15). 
 
a
 
-phenyl-
 
tert
 
-butyl nitrone (PBN) has been
used for the detection of ROI in various experimental systems
(18). Only recently has PBN been discovered to have a benefi-
cial effect on oxidative injury of the CNS. PBN administration
protected rats from ischemic, traumatic, and excitotoxic brain
injury and reduced endotoxin induced mortality (2, 7, 19–24).
PBN showed no toxicity at the dosage used and the brain con-
centrations have been demonstrated to be significantly higher
than those in blood (25). The high CNS penetration of PBN, a
result of its lipophilicity, makes this compound an attractive
tool to explore the role of ROI in various diseases that lead to
brain injury. In the present study, we used an infant rat model
of neonatal meningitis, in which extensive brain injury devel-
ops, to explore the hypothesis that meningitis leads to the gen-
eration of ROI, that PBN can reduce the generation of ROI,
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and that scavenging of ROI by PBN exerts a neuroprotective
effect.
 
Methods
 
Infecting organism. 
 
A group B 
 
streptococcus
 
 type III (GBS; gener-
ously provided by Dr. Craig Rubens, University of Washington, Seat-
tle, WA), one of the most common types causing neonatal meningitis,
was used as described previously (14, 26). The organism was cultured
overnight in Todd Hewitt broth, then diluted in fresh medium, grown
to logarithmic phase, pelleted, and resuspended in normal saline to
the desired density and used for infection.
 
Model of meningitis. 
 
Nursing Sprague-Dawley rat pups with their
dam were purchased (Simonsen, Gilroy, CA) and infected on postna-
tal day 11 by direct intracisternal injection of 10 
 
m
 
l of a suspension of
GBS, using a 32-gauge needle as described in (26). The inoculum size
was 1 
 
3
 
 10
 
6
 
 cfu/ml in the pretreatment group (
 
n
 
 
 
5
 
 20) and between
1 
 
3
 
 10
 
5
 
 to 1 
 
3
 
 10
 
6
 
 cfu/ml in the posttreatment group (
 
n
 
 
 
5
 
 52). 18 h af-
ter infection, pups were weighted and assessed clinically. To docu-
ment meningitis, 10 
 
m
 
l of cerebrospinal fluid (CSF) was obtained by
puncture of the cisterna magna, and cultured quantitatively. In a sub-
set of animals, white blood cell (WBC) count was assessed in CSF
samples by standard hematocytometer method. Animals were then
treated with the antibiotic ceftriaxone (Hoffmann-La Roche, Nutley,
NJ), 100 mg/kg subcutaneously once daily. Animals were killed with
an overdose of pentobarbital at the predetermined timepoints or
when they became terminally ill (cyanotic, difficulty breathing, pro-
tracted seizures). Animals dying unobserved were excluded from the
evaluation.
 
Bacterial cultures. 
 
Serial dilutions of CSF in saline were cultured
on blood agar plates incubated for 24 h at 37
 
8
 
C with 5% CO
 
2
 
. In one
experiment, infected animals were pretreated with PBN (100 mg/kg
i.p. every 8 h, 
 
n
 
 
 
5
 
 5) or saline (
 
n
 
 
 
5
 
 5) and killed immediately after the
cisternal tap. 10 
 
m
 
l of blood was drawn from the left cardiac ventricle
and cultured in parallel with the CSF samples. To assess a possible ef-
fect of PBN on bacterial growth, GBS was cultured overnight in Todd
Hewitt broth, then equally diluted in fresh medium without (
 
n
 
 
 
5
 
 2) or
with PBN (Aldrich Chem. Co., Milwaukee, WI) at 10 mM (
 
n
 
 
 
5
 
 3).
This concentration corresponds to the maximally effective concentra-
tion protecting neurons from glutamate-induced toxicity in vitro (19),
and exceeds the concentration of PBN in the CNS after a dose of 150
mg/kg i.p. in rats (25). After incubating all cultures for 210 min at
37
 
8
 
C with 5% CO
 
2
 
, the density of the organisms was determined by
quantitative subcultures.
 
Detection of ROI. 
 
For direct demonstration of the production of
ROI in vivo, a cytochemical method previously described for the de-
tection of superoxide in cerebral inflammation was adapted (1). In-
fant rats (seven uninfected controls; eight infected animals, and four
infected animals pretreated with PBN, 100 mg/kg i.p. every 8 h) were
perfused with 40 ml of citrate buffer containing 40 mM of manganese
(MnCl
 
2
 
) at the time of death. Brains were immediately frozen on dry
ice, sectioned in a cryostat, and mounted on gelatinized slides. Sec-
tions where then incubated with a citrate buffer containing MnCl
 
2
 
(40 mM) and 1 mg/ml diaminobenzidine (DAB; Sigma Chemical Co.,
St. Louis, MO), counterstained with methyl green, air dried, and cov-
erslipped. The brownish color reaction was used to assess ROI pro-
duction, and was documented by photography.
 
Lipidperoxidation. 
 
The concentrations of malonaldehyde and
4-hydroxyalkenals, the endproducts of lipidperoxidation, provide a
reliable index of the extent of oxidative damage to cell membranes
(27, 28). Rat pups were randomly assigned to three experimental
groups. Uninfected controls (
 
n
 
 
 
5
 
 8), infected animals (
 
n
 
 
 
5
 
 8), and an-
imals infected and pretreated with PBN (100 mg/kg i.p. every 8 h;
 
n
 
 
 
5
 
 6) were killed 20 h after infection. Brains were placed in ice-cold
Tris-HCl (pH 7.4), the cortices were dissected, washed, snap frozen in
liquid nitrogen, and stored at 
 
2
 
70
 
8
 
C. 400 mg tissue was homogenized
and diluted in Tris-HCl to 25% (wt/vol) on ice. After centrifugation at
3,000 
 
g
 
 for 10 min at 4
 
8
 
C, 200 
 
m
 
l of supernatant was assessed for the
concentration of the lipidperoxidation endproducts using a lipid per-
oxidation assay kit (Calbiochem, San Diego, CA) following the man-
ufacturers instructions. The reaction of either lipidperoxidation prod-
uct with the chromogenic reagent yielded a stable endproduct after
incubation at 45
 
8
 
C for 40 min. The reaction was stopped on ice and
the absorbance was measured at 586 nm. Using standard curves gen-
erated with samples of malonaldehyde and 4-hydroxyalkenal, the
concentration of the chromophore in the solutions was calculated and
expressed as micromolar per milligram of tissue.
 
Histopathology. 
 
After a lethal dose of pentobarbital, animals
were perfused via the left cardiac ventricle with 60 ml of 4%
paraformaldehyde in phosphate-buffered saline (pH 7.4). For histo-
pathological examination brains were postfixed overnight in 5 ml of
4% paraformaldehyde in PBS (pH 7.4) at 4
 
8
 
C, then placed in 30% su-
crose in PBS and cut at 50-
 
m
 
m intervals on a vibratome (29). Sections
were mounted on gelatinized glass slides for staining. After dehydra-
tion, sections were Nissl stained in cresyl violet, and slides were rehy-
drated and coverslips were fixed with Permount. For quantitative
evaluation, sections were examined for cortical neuronal injury, de-
fined as areas of decreased density of neurons or frank cortical necro-
sis. 12 cortical sections spanning the middle half of the brain were
scored in each animal for the presence or absence of neuronal injury,
as described elsewhere (14), and the average injury score for each in-
dividual animal was used for statistical analysis. Similarly, injury to
the dentate granule cell layer of the hippocampus was scored in each
section containing the structure (14). The histopathologic evaluations
were performed by an investigator blinded to the clinical, microbio-
logical, and treatment data of animals.
 
Time-course experiments. 
 
To determine the optimal timepoint for
pharmacological interventions, we assessed the earliest timepoint and
the evolution of histopathologically discernible neuronal injury in the
model. Animals (
 
n
 
 
 
5
 
 18) were killed at predetermined timepoints
(4, 12, 18, 20, 22, 24, and 36 h) and evaluated histopathologically, as
described above.
 
Detection of apoptosis in situ. 
 
Infected animals (
 
n
 
 
 
5
 
 6) were killed
at 18, 24, and 36 h after infection together with age-matched controls
(
 
n
 
 
 
5
 
 3). Brains were processed as described for histopathological
evaluation but postfixed for only 2 h. Three alternate sections of the
midbrain region were cut at 50-
 
m
 
m intervals. One section was used
for morphological evaluation by Nissl staining and two sections (sam-
ple and negative sham-stained control) were processed for the in situ
detection of cells containing high amounts of fragmented DNA using
a commercially available apoptosis detection kit (ApopTag
 
®
 
; Oncor,
Gaithersburg, MD). Briefly, labeling of 3
 
9
 
-OH DNA ends visualized
pyknotic nuclei with stainable concentration of DNA fragments as
described (30). Digoxigenin-nucleotide residues added to the 3
 
9
 
-OH
end of the DNA by terminal deoxynucleotidyl transferase were rec-
ognized by peroxidase conjugated antidigoxigenin antibodies. The lo-
calized peroxidase enzyme generated a signal from DAB as the chro-
mogen. After counterstaining with methyl green, positive cells were
counted by lightmicroscopy and expressed as percentage of total cell
count within the structure of the dentate granule cell layer. As a posi-
tive control we used sections of normal female rat mammary gland
3–5 d after weaning of the pups. Negative controls included sham-
stained sections (Terminal deoxynucleotidyl transferase substituted
with distilled water) and tissue from uninfected animals.
 
Assessment of cerebral cortical perfusion. 
 
We examined cere-
bral cortical perfusion by intracardiac injection of the freely diffusible
dye neutral red (Sigma Chemical Co.) using modifications of pub-
lished procedures (31–34). Animals were infected with log
 
10
 
 5.8
 
6
 
0.2
cfu/ml or injected with saline and treatment with PBN (100 mg/kg i.p.
q 8 h) was started at the time of infection. Animals were anesthetized
by intraperitoneal injection of sodium pentobarbital (100 mg/kg) at
20 h after infection, and 1 ml of a 3.6% solution of neutral red in sa-
line (pH 7.0, twice filtered) was perfused through the contracting left
cardiac ventricle over 45 s at a constant rate (1.36 ml/min). 75 s after
the end of the infusion, rats were decapitated and brains harvested
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and placed on dry ice. Cortical sections were cut on a cryostat at
50 
 
m
 
m and mounted on gelatinized glass slides. For computer-assisted
quantitation of the dye density, sections were scanned on a flat bed
scanner (Color One Scanner; Apple Computer, Cupertino, CA) and
the digitized images were analyzed using the public domain NIH Im-
age program (U.S. National Institutes of Health, Bethesda, MD).
Mean cortical dye density in infected animals was expressed as per-
centage of density in uninfected control animals.
 
Effect of PBN on neuronal injury. 
 
The effect of PBN on neu-
ronal injury scores in the infant rat model of neonatal meningitis was
examined in two experiments. To attenuate ROI-mediated processes
early in the course of meningitis and to maximize the effect of treat-
ment, animals were randomized to pretreatment with PBN (100 mg/
kg i.p. every 8 h ; 
 
n
 
 
 
5
 
 10) or saline (
 
n
 
 
 
5
 
 10) in a first set of experi-
ments. Animals were examined clinically, CSF cultures were ob-
tained 18 h after infection, and brain injury scores were assessed be-
tween 22 and 24 h after infection. To evaluate the effect of delayed
PBN administration on the outcome in fully developed meningitis,
treatment was started together with antibiotics at 18 h after infection.
PBN (100 mg/kg i.p., 
 
n
 
 
 
5
 
 28) or saline (
 
n
 
 
 
5
 
 24) was administered at
18 h after infection (simultaneously with the first dose of ceftriaxone),
22, 26, 30 h and then continued with a dosing interval of 8 h until ani-
mals were killed 48 h after infection.
 
Statistics. 
 
Bacterial titers and lipidperoxidation endproducts are
presented as mean 
 
6
 
 SD and differences between groups were ana-
lyzed by Student’s 
 
t
 
 tests. Proportions between different groups were
compared by Fisher’s exact test. Scores between groups were com-
pared by the Mann-Whitney rank sum test.
 
Results
 
Characterization of the disease. 
 
By 18 h after infection, all in-
fected animals had meningitis, as evidenced by positive bacte-
rial titers in the CSF. Treatment of animals with PBN, begin-
ning at the time of infection, led to CSF bacterial titers that
were significantly higher than in untreated infected animals
(log
 
10
 
 10.1
 
6
 
0.7 cfu/ml vs log
 
10
 
 8.0
 
6
 
0.4 cfu/ml; 
 
P
 
 
 
,
 
 0.001).
Blood cultures performed in selected animals with meningitis
showed a consistent 100-fold reduction in blood titers relative
to the CSF titers, both in saline-treated control animals and in
animals treated with PBN, and thus a higher level of bactere-
mia in PBN-treated animals than in controls (
 
P
 
 
 
,
 
 0.02). The
increased bacterial titers in the PBN-treated animals did not
appear to result from a growth-promoting effect of PBN, since
PBN at 10 mM had no significant effect on bacterial growth in
vitro (log
 
10
 
 8.9
 
6
 
1.2 vs 9.1
 
6
 
0.6 cfu/ml; 
 
P
 
 
 
5
 
 NS). CSF leukocyte
counts showed no significant difference between infected
animals treated with PBN and those treated with saline
(6,420
 
6
 
7,255 vs 7,720
 
6
 
7,585 cells/mm
 
3
 
; 
 
P
 
 
 
5
 
 NS). This suggests
that the mechanism, by which PBN treatment leads to in-
creased bacterial titers is related to scavenging of ROI pro-
duced by inflammatory cells, rather than to a negative effect
on the recruitment of leukocytes into the CSF. Clinically, ani-
mals with meningitis were lethargic to obtunded 18 h after in-
fection, with no obvious difference between animals treated
with PBN and saline. In the posttreatment experiments, CSF
bacterial titers at the time of institution of therapy were identi-
cal in the two experimental groups (log
 
10
 
 8.7
 
6
 
0.7 vs 8.7
 
6
 
0.4
cfu/ml; 
 
P
 
 
 
5
 
 NS).
In histopathologic studies, the first granulocytes were seen
in the subarachnoid space 4 h after intracisternal infection.
CSF inflammation was fully developed by 18 h and always in-
volved both the subarachnoid and ventricular space. Nissl
staining with cresyl violet revealed two distinct forms of neu-
ronal injury, necrotic cortical injury and selective injury to the
dentate gyrus of the hippocampus. In the cortex, the injury
pattern consisted of areas of reduced neuronal density with
neurons displaying morphologic features of necrosis, including
cell swelling and loss of cytoarchitecture (Fig. 1 
 
A
 
). Foci of
neuronal injury appeared throughout the cortex and tended to
be wedge-shaped and thus suggestive of ischemic damage (Fig.
1 
 
B). The earliest evidence of injury appeared in animals ex-
amined 18 h after infection, where one animal had incomplete,
band-like areas of reduced neuronal density with intact neu-
rons in the core of the lesions (26), while the two other animals
studied at this time point had no evidence of neuronal drop
out. All infected animals studied at subsequent time points in
this experiment had evidence of injury, with the foci of necro-
sis becoming more extensive in animals studied after 22 h or
later.
The pattern of injury in the hippocampus was distinctly dif-
ferent from that in the cortex. Beginning 18 h after infection,
neurons in the granule cell layers of the dentate gyrus, pre-
dominantly in the lower blade, became markedly condensed,
rounded and shrunken, showing morphological features char-
acteristic for apoptosis (Fig. 1 C). Staining by in situ end-label-
ing of fragmented DNA, a hallmark of apoptosis, revealed
positive cells bilaterally in the dentate granule cell layer of the
hippocampus, with a predominance in the lower blade (Fig. 1
D). The stain was exclusively detectable in nuclei showing
morphological signs of apoptotic death by Nissl stain (Fig. 1
C). Within the granule cell layer, the percentage of positive
neurons were 8.663.3%. Other structures in the hippocampus,
specifically the CA1 and CA3 region showed no positively
stained cells and no evidence of neuronal damage by Nissl
stain. Occasionally, single cells (, 1% of all cells) were posi-
tive in the cortex in areas of cortical injury. In addition, many
inflammatory cells in the subarachnoid and ventricular space
were positive. No positive signal was detected in uninfected
animals and in infected animals showing no injury to the hip-
pocampal dentate granule cell layer.
Production of ROI and oxidative brain injury. Evidence for
the production of ROI in meningitis was obtained by the de-
tection of superoxide in vivo by the manganese/DAB (DAB)
method (1). Meningitis led to the generation of superoxide in
all infected, untreated animals examined 18 h after infection
(n 5 8). Superoxide-derived DAB polymers colocalized with
the inflammatory cells (predominantly granulocytes) in the
subarachnoid and ventricular space and were also consistently
seen along penetrating cortical vessels (Fig. 1 E). In one ani-
mal, foci of early cortical injury showed scattered individual
cells positive for DAB polymers within the superficial brain
parenchyma (Fig. 1 F). Their size and localization indicated
that these cells were distinct from neurons (Fig. 1 F). In an ad-
ditional animal, the dentate gyrus was markedly positive bilat-
erally. None of the infected animals treated with PBN (n 5 4)
showed DAB polymers (P , 0.01 vs infected, untreated ani-
mals) documenting that PBN effectively bound and neutral-
ized ROI produced by the meningitic process. Also, all unin-
fected control animals (n 5 7) were manganese/DAB staining
negative.
Meningitis also led to a marked increase of the concentra-
tion of the lipid peroxidation endproducts malonaldehyde and
4-hydroxyalkenals 18 h after infection. In infected animals, the
concentrations of these two products in homogenized brain tis-
sue was 4.060.5 mM/mg tissue (n 5 8), compared with 2.360.5
Downloaded from http://www.jci.org on July 16, 2015.   http://dx.doi.org/10.1172/JCI119084
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Figure 1. (A–F) Brain histology of saline treated infant rats with group B streptococcal meningitis. (A) Cortical injury in an animal 24 h after in-
fection. Area of markedly reduced neuronal density containing neurons with morphologic features of necrosis, including cell swelling, loss of cel-
lular demarcation, and fading of cytoarchitecture (white arrows and inset). Focus of neuronal loss is sharply demarcated from area with pre-
served neurons (black arrow). (Cresyl violet, 3400; inset 31,200). (B) Whole brain section of an animal 36 h after infection showing extensive 
neuronal injury throughout the cortex in a wedge-shaped pattern suggestive of ischemic damage (black arrows). (Cresyl violet, 35). (C) Neu-
ronal injury to the lower blade of the dentate granule cell layer in the hippocampus of an animal 36 h after infection. Part of the blade consists of 
neurons with condensed, shrunken, and eccentric nuclei (black arrow and inset) showing morphological features compatible with apoptosis. Un-
injured neurons of the structure are visible in the right upper quadrant. (Cresyl violet, 3400; inset 32,000). (D) Staining by in situ end-labeling of 
fragmented DNA, a hallmark of apoptosis, revealed positive cells bilaterally in the dentate granule cell layer of the hippocampus (white arrows) 
in an animal 24 h after infection. A positive signal was exclusively detectable in nuclei showing morphological signs of apoptotic death by stain-
ing with cresyl violet. (ApopTag® peroxidase kit, counterstained with methyl green, 3200). (E) ROI production visualized by manganese/DAB 
method was seen in association with the subarachnoid space inflammation (white arrow) and along penetrating cortical vessels (black arrow). 
(DAB, counterstained with methyl green, 3200). (F) In an area of early cortical injury, individual cells showed positive staining for superoxide 
production by the manganese/DAB method (white arrows) in addition to the positive signals in the subarachnoid space and the cortical vascula-
ture (black arrow). The DAB-positive cells appear to be smaller than and distinct from neurons. (DAB, counterstained with methyl green, 
3400).
Downloaded from http://www.jci.org on July 16, 2015.   http://dx.doi.org/10.1172/JCI119084
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mM/mg tissue in uninfected animals (n 5 8; P , 0.001). Pre-
treatment of infected animals with PBN (n 5 6) completely
prevented this increase in brain lipidperoxidation products
(2.260.2 mM/mg tissue; P , 0.001 vs infected, untreated ani-
mals; P 5 NS vs uninfected controls).
Effect of PBN on cerebral cortical perfusion. In animals
with meningitis (n 5 6), cortical perfusion, as determined by
assessing the mean optical dye density in cortical sections, was
significantly reduced to 37.5621.0% of uninfected controls
(n 5 4; P , 0.05). Treatment with PBN (n 5 10) significantly
improved cortical perfusion (72.068.1% of uninfected con-
trols; P , 0.05 vs infected, untreated animals, NS vs uninfected
controls).
Effect of PBN treatment on neuronal injury. In a first set
of experiments, we initiated therapy with PBN at the time of
infection to maximize the potentially beneficial effects of PBN
on neuronal injury. Five of 10 (50%) infected, saline-treated
control animals showed histopathological evidence of neu-
ronal injury in the cortex. All five animals also had damage in
the hippocampus. Pretreatment with PBN (100 mg/kg q8h i.p.)
completely abolished the development of brain injury (P , 0.02,
Fig. 2, A and B). This protective effect was seen despite the
significantly higher CSF bacterial titers in the animals treated
with PBN (see above). PBN treatment in uninfected control
animals had no clinical or histopathological effects.
The second set of experiments was performed to explore
whether delayed administration of PBN still protected the
brain from injury. Our time-course experiments (see above)
indicated that the earliest histopathologic evidence of neu-
ronal injury in this model appeared approximately 18 h after
infection, and that there was noticeable progression of the ex-
tent of injury in the next few hours. The progression of injury
was also evident from the comparison of control animals ex-
amined at 24 h (Fig. 2) with those examined at 48 h (Fig. 3).
We therefore initiated treatment with antibiotics in combina-
tion with PBN or saline at 18 h, with the assumption that an ef-
fective treatment would prevent some, but not all injury. In-
jury scores (median and range) in the infected control animals
were 1.6 (0–7) for cortical injury and 0.4 (0–3.7) for hippocam-
pal injury. The extent of injury was significantly reduced by
PBN treatment: 0.03 (0–4.5) for cortical injury (P , 0.004, Fig.
3 A), and 0 (0–1.3) for hippocampal injury (P , 0.001, Fig. 3
B). Thus, initiation of PBN treatment at a time point where
neuronal injury started to appear was still highly effective in
preventing progression of injury.
Discussion
ROI have been implicated as mediators of brain injury in a
wide variety of disease processes, including chemically induced
cerebral inflammation (1), ischemia/reperfusion injury (6, 7,
22), brain edema (12, 35), neuronal apoptosis (36–39), and ex-
citotoxic neuronal injury (4, 40–42). Pathophysiologic pro-
cesses characteristic of bacterial meningitis, such as vascular
endothelial cell activation and neutrophil adherence, sub-
arachnoid space inflammation, blood-brain barrier disruption,
brain edema, and excitotoxicity may also involve the genera-
tion of ROI (1, 35, 39, 43, 44). The present study provides
strong evidence that ROI-mediated processes are critical in
bacterial meningitis, and that inactivation of ROI by binding
to the free radical scavenger PBN is a highly effective strategy
to reduce neuronal damage in this disease.
Conceptionally, the course of bacterial meningitis can be
divided into three phases. First, invading microorganisms gen-
erate an inflammatory response in the subarachnoid space;
second, the cerebral vasculature reacts to the inflammation
with cerebral hyperemia, followed later by cerebral ischemia;
and third, cellular and molecular changes in the brain paren-
chyma lead to permanent brain injury. The generation of an
inflammatory reaction, including the transcriptional regulation
of cytokines and the expression of adhesion molecules on en-
dothelial cells necessary to recruit granulocytes have been
shown to involve ROI (43, 44). Nevertheless, CSF white blood
cell counts were not significantly affected by the treatment
with PBN, and histopathologic examination of the subarach-
noid and ventricular inflammation also failed to show an obvi-
ous effect of pretreatment with PBN on the extent of inflam-
mation in the present study. It appears therefore that PBN
exerted its beneficial effects by mechanisms other than reduc-
ing the extent of CSF inflammation. With regard to the pros-
pects of developing a drug such as PBN for the adjunctive
therapy of bacterial meningitis, this may represent an advan-
tage, since CSF inflammation is typically well developed, when
patients with meningitis seek medical attention.
At the site of inflammation, activated polymorphonuclear
leukocytes produce high concentrations of ROI (1). This was
Figure 2. Effect of PBN (100 mg/kg PBN q8h i.p.), beginning at the 
time of infection, on neuronal injury in the cortex (A) and hippocam-
pus (B). In saline-treated control animals, GBS meningitis led to his-
topathological evidence of neuronal injury in the cortex and hippo-
campus of 50% of animals. Pretreatment with PBN (100 mg/kg q8h 
i.p.) completely abolished the development of brain injury.
Figure 3. Effect of PBN (100 mg/kg PBN q4h - q8h i.p.) on neuronal 
injury in the cortex (A) and hippocampus (B), when started at 18 h 
after infection, at the time of institution of antibiotic therapy. PBN 
was highly protective for both forms of injury, the necrotic injury in 
the cortex, and the apoptotic injury in the dentate gyrus.
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confirmed in our studies using Mn/DAB staining, which
showed markedly positive signals that colocalized with the in-
flammatory cells in the subarachnoid space and was abolished
by PBN treatment. Treatment with PBN started at the time of
infection abolished completely the detection of ROI by man-
ganese/DAB staining and resulted in 100-fold higher CSF bac-
terial titers 18 h later. This suggests that ROI produced in the
CSF space play a role as host defense mechanism against the
group B streptococci. This is a new finding that contrasts with
previous studies, where the absence of granulocytes, appar-
ently the major source of ROI in the CSF, did not increase the
growth rate or final titers of pneumococci (45, 46). This dis-
crepancy may indicate that ROI produced in the subarachnoid
space by cells other than neutrophils contribute to host de-
fenses against bacterial pathogens, or that group B streptococci
are more susceptible to the bactericidal effect of ROI than
pneumococci. Importantly for the scope of the present study,
the higher CSF bacterial titers were not associated with in-
creased brain injury, indicating that bacteria per se, without
the mediation of inflammation, cause little, if any damage.
Inflammation in the subarachnoid space surrounds blood
vessels and can extend into the cortical parenchyma along the
perivascular Virchow-Robins spaces. ROI production local-
ized to the brain vasculature in the cortex was clearly demon-
strated in the present study. During cerebral inflammatory
states, endothelial cells and vascular smooth muscle cells have
been identified as cellular sites of ROI production in the rat
brain microvasculature (1). The colocalization of ROI produc-
tion with cerebral blood vessels suggests that ROI may con-
tribute to the changes of cerebral blood flow observed during
bacterial meningitis (10, 47). In a study in rats using a cranial
window preparation, exposure of pial arterioles to live and
killed GBS produced a marked and progressive vasodilatation
which was prevented by ROI scavengers (11). Similarly, ROI
scavengers reduced the early hyperemia and brain edema in an
adult rat model of pneumococcal meningitis (35). Whether
prevention of this early hyperemia by scavengers of ROI is an
important component of the neuroprotective effect of PBN
was not addressed in the present study. ROI can also contrib-
ute to endothelial cell lesions that lead to the disruption of the
blood–brain barrier and facilitate neutrophil adherence (35).
PBN administration early in meningitis is likely to improve
some of these potentially deleterious effects of inflammation
and microcirculatory derangements.
As meningitis advances, cerebral blood flow starts to de-
cline (48, 49), and clinical studies have found an association
between severe cerebral blood flow reduction and adverse
outcomes (50–52). Cerebral blood flow reduction during men-
ingitis can be global, as a result of reduced cerebral perfusion
pressure (49), or focal. Vasculitis of cerebral arteries and veins
caused by the surrounding subarachnoid space inflammation
may lead to temporary vasospasm or to permanent thrombo-
sis, resulting in focal cerebral ischemia (10, 47, 53). The pro-
nounced ROI production associated with the cerebral vascula-
ture and the marked restitution of cerebral cortical perfusion
by PBN in our model indicate that ROI play a critical role in
the vascular events during meningitis that lead to cerebral hy-
poperfusion. Processes that may be attenuated by inactivation
of ROI through scavenging with PBN include vasomotor re-
sponses, leukocyte–endothelial cell interactions, platelet acti-
vation, and intracranial pressure (11, 35, 44, 54). The improve-
ment of cerebral perfusion resulting from scavenging of ROI
conceivably is an important reason for the neuroprotective ef-
fect of PBN in the present model, particularly when PBN was
started at the time of infection and thus largely prevented the
development of cerebral ischemia.
Cerebral ischemia leads to an increase in extracellular con-
centrations of excitatory amino acids, which results in exces-
sive activation of neuronal receptors and excitotoxic cell death
(40, 42). Previous studies documented that excitotoxicity plays
a role in mediating neuronal injury in bacterial meningitis (13,
55). The production of excitotoxic neuronal injury is tightly
linked to the generation of ROI, in that stimulation of neurons
with excitatory amino acids leads to the production of ROI
(15, 40), and that induction of oxidative injury in the hippo-
campus by exposure to ROI-generating substrates leads to the
release of excitatory amino acids (42). Furthermore, activation
of glial cells, an early event in bacterial meningitis (Leib, S.L.,
and M.G. Taüber, unpublished observations), involves the
generation of ROI (56, 57). Exposure of glia to ROI has been
shown in vitro to block clearance of excitatory amino acids by
inhibiting specific uptake mechanisms (58). The link between
oxidative and excitotoxic injury has the potential to lead to a
vicious circle, which may propagate injury even after the initi-
ating insult has been removed (42). Consequently, scavengers
of ROI consistently attenuate excitotoxic injury in vitro and in
vivo (4, 41). It is likely that a component of the beneficial ef-
fect of PBN in our model is related to the scavenging of ROI in
ischemically injured brain parenchyma, particularly when PBN
treatment was instituted in well established meningitis.
Our study has provided evidence for two distinct forms of
neuronal injury. In the cortex, foci of neuronal injury showed
many features suggestive of ischemic damage, such as wedge-
shaped lesions, swollen neuronal cell bodies with loss of cy-
toarchitecture, and association with vascular involvement. In
contrast, injury in the dentate granule cell layer of the hippo-
campus showed features characteristic for apoptosis. Several
lines of evidence have recently supported a role for ROI in
causing apoptosis in neurons (36, 37). In the immature rat,
neurons of the hippocampal dentate granule cell layer were
among the first to undergo apoptotic cell death in a recent
study of hypoxic–ischemic injury, with the characteristic mor-
phology and DNA fragmentation observed as early as 10 h af-
ter the hypoxic insult (59). Both forms of injury in our menin-
gitis model, necrotic cortical injury and apoptotic hippocampal
injury were markedly attenuated by treatment with PBN. This
suggests that for both forms of neuronal injury ROI produc-
tion is critical, even though the detailed mechanisms of ROI-
mediated injury may well differ between the two forms.
Even though all infected animals had meningitis and evi-
dence of oxidative injury, not all developed brain injury. This
does, however, not exclude a critical role of ROI in causing
brain injury in this model. First, the development of histologi-
cally apparent injury was time dependent, and in the after-
treatment experiments almost all animals had some degree of
injury. Second, there is almost invariably a range of severity of
changes in animal models such as ours. For example, the con-
centrations of lipidperoxidation products in our study ranged
from 3.3 to 4.9 mmol/mg tissue, the lower values being only
slightly higher than the upper range of uninfected animals, de-
spite the uniform presence of meningitis in the infected ani-
mals. Inspection of brain slices stained with DAB indicated
that, while all animals had positive signals, their extent also
was variable. Thus, the fact that not all animals had injury, par-
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ticularly at the earlier time point studied, seems to reflect the
variability inherent in animal models, rather than argue
against a causative role of ROI in brain injury in this model of
meningitis.
In summary, this study documents a critical role of ROI
production in the pathogenesis of neuronal injury in a model
of neonatal GBS meningitis. We have localized the generation
of ROI primarily to cells constituting the subarachnoid and
ventricular inflammation and to the cerebral vasculature, and
have documented the occurrence of lipidperoxidation. Fur-
thermore, inhibition of the biological effect of ROI with the
free radical scavenger PBN significantly improved cerebral
cortical perfusion and reduced the extent of both necrotic and
apoptotic neuronal injury. This is the first report to demon-
strate a significant beneficial effect of a radical scavenger on
the neuropathologic outcome in bacterial meningitis.
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